-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Chemomab Therapeutics Ltd. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q2 2024.
- Chemomab Therapeutics Ltd. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 286M shares, a 29.1% increase year-over-year.
- Chemomab Therapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 235M shares, a 3.26% increase from 2022.
- Chemomab Therapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 228M shares, a 9.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)